Boston An independent LDT provider

Press releases

August 3, 2018

Karolinska Institutet participates in Immunovia’s PanFAM-1 prospective  clinical study for early detection of pancreatic cancer using blood-based test

Read press release
June 29, 2018 | REGULATORY

Change in number of shares and votes in Immunovia AB (publ)

Read press release
June 8, 2018 | REGULATORY

Immunovia has completed a directed share issue of approximately SEK 324 million

Read press release
June 7, 2018 | REGULATORY

Immunovia announces its intent to carry out a directed share issue

Read press release
May 22, 2018

Linköping University Hospital second Swedish site in largest ever prospective multicenter clinical study for early detection of pancreatic cancer

Read press release
May 4, 2018

Spanish major private hospital joins world’s largest study of familiar risk for pancreatic cancer

Read press release
May 3, 2018 | REGULATORY

Immunovia—report from AGM

Read press release
April 27, 2018 | REGULATORY

Immunovia Interim report, January-March 2018

Read press release
April 25, 2018

Invitation to presentation of Immunovia´s interim report January-March 2018 on April 27, 2018

Read press release
April 25, 2018

Invitation to presentation of Immunovia´s interim report January-March 2018 on April 27, 2018

Read press release
April 12, 2018

NYU School of Medicine joins PanFAM-1 prospective study for the early detection of pancreatic cancer in familiar risk groups

Read press release
April 3, 2018 | REGULATORY

Kallelse till Årsstämma i Immunovia AB

Read press release
1 21 22 23 24 25 31